The Durham company, Ummino, is targeting the sharp rise in consumer demand for fortified food and beverage products. Its ...

As algae blooms fed by chemical fertilizer runoff from farms and lawns contaminate more waterways every year, a North Carolina company is rooting its future in high-end eco-sensitive plant-growing ...

The event organizers selected Raleigh for their inaugural event given the Triangle region’s reputation for being an important ...

Novo Nordisk has officially begun building a $1.8 billion production facility for diabetes medicines at its Clayton site that will create 700 high-paying jobs, doubling its workforce there. The ...

Bamboo Therapeutics, a next-generation gene therapy company based in Chapel Hill, has been acquired by the pharmaceutical giant Pfizer of New York. Pfizer, which had acquired a 22 percent stake in ...

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, will relocate its headquarters from San Diego, California, to Cary, North Carolina, effective Jan. 1, 2025, according ...

The North Carolina Biotechnology Center awarded 14 grants and loans totaling $1,287,335 to bioscience companies, universities and non-profit organizations in the first quarter of its fiscal year. The ...

Raleigh-based Innovate Biopharmaceuticals, a clinical stage biotechnology company focused on developing novel autoimmune and inflammation therapeutics, has completed its reverse merger with California ...

This free event will showcase North Carolina’s biologics and pharmaceutical (biopharma) manufacturing educational and career opportunities statewide. Hear from a panel of recent grads who have ...

Durham-based Humacyte, founded by three female scientists in 2004, has received marketing approval from the U.S. Food and Drug Administration for its first product – a groundbreaking bioengineered ...